Navitoclax combined with Alpelisib effectively inhibits Merkel cell carcinoma cell growth in vitro

BACKGROUND: Merkel cell carcinoma (MCC) is a highly malignant skin cancer. Despite major treatment improvements during the last decade, up to 50% of patients do not respond to therapy or develop recurrent disease. For these patients, alternative treatment options are urgently needed. Here, we assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Chteinberg, Emil, Wetzels, Suzan, Gerritsen, Wouter, Temmerman, Lieve, van den Oord, Joost, Biessen, Erik, Kurz, Anna Kordelia, Winnepenninckx, Véronique, Zenke, Martin, Speel, Ernst-Jan, zur Hausen, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739210/
https://www.ncbi.nlm.nih.gov/pubmed/33403016
http://dx.doi.org/10.1177/1758835920975621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739210/
https://www.ncbi.nlm.nih.gov/pubmed/33403016
http://dx.doi.org/10.1177/1758835920975621

Ejemplares similares